Hartaj Singh analyst

Currently out of the existing stock ratings of Hartaj Singh, 227 are a BUY (96.6%), 8 are a HOLD (3.4%).

Hartaj Singh

Work Performance Price Targets & Ratings Chart

Analyst Hartaj Singh, carries an average stock price target met ratio of 44.98% that have a potential upside of 32.61% achieved within 306 days. Previously, Hartaj Singh worked at OPPENHEIMER, BTIG.

Hartaj Singh’s has documented 439 price targets and ratings displayed on 36 stocks. The coverage was on Healthcare, Industrials, Consumer Defensive sectors.

Most recent stock forecast was given on VRTX, Vertex Pharmaceuticals at 05-May-2026.

Wall Street Analyst Hartaj Singh

Analyst best performing recommendations are on ONCT (ONCTERNAL THERAPEUTICS).
The best stock recommendation documented was for MRNA (MODERNA) at 4/15/2020. The price target of $43 was fulfilled within 2 days with a profit of $5.75 (15.44%) receiving and performance score of 77.18.

Average potential price target upside

ALXN Alexion Pharmaceuticals CATB Catabasis Pharmaceuticals GILD Gilead Sciences INO Inovio Pharmaceuticals LIFE aTyr Pharma MRNA Moderna REGN Regeneron Pharmaceuticals SBBP Strongbridge Biopharma plc SNSS Sunesis Pharmaceuticals UTHR United Therapeutics VIRX Viracta Therapeutics VRTX Vertex Pharmaceuticals SRPT Sarepta Therapeutics ELOX Eloxx Pharmaceuticals BMEA Biomea Fusion FSTX FStar Therapeutics ONCT Oncternal Therapeutics SPRB Spruce Biosciences GANX Gain Therapeutics ATXS Astria Therapeutics CLLS Cellectis SA ICVX Icosavax NBSE NeuBase Therapeutics OPT Opthea Ltd ORTX Orchard Therapeutics PLC TRDA Entrada Therapeutics ARQL ArQule CELG Celgene SNDX Syndax Pharmaceuticals BNTX BioNTech SE AL Air Lease ALLO Allogene Therapeutics CAT Caterpillar EL Estee Lauder Companies SN SharkNinja HARP Harpoon Therapeutics

Analyst name

Rating

Current price target

Potential Upside

Previous price target

Date of last PT

Price targets met ratio

Average potential upside

Average Days to Hit Target

Performance score

Buy Since 28-Jul-2017

$205

$22.5 (12.33%)

5 years 5 months 9 days ago
(05-May-2021)

3/5 (60%)

$35.09 (20.65%)

938

Hold Since 03-May-2021

$173

$-9.5 (-5.21%)

$156

5 years 5 months 11 days ago
(03-May-2021)

17/29 (58.62%)

$2.73 (1.60%)

650

Hold Since 04-Feb-2021

$190

$7.5 (4.11%)

$190

5 years 5 months 18 days ago
(26-Apr-2021)

11/14 (78.57%)

$23 (13.77%)

420

Buy Since 06-Sep-2019

$175

$-7.5 (-4.11%)

$165

5 years 8 months 10 days ago
(04-Feb-2021)

3/3 (100%)

$19.41 (12.48%)

397

Buy Since 17-Jul-2017

$166

$-16.5 (-9.04%)

$175

5 years 8 months 10 days ago
(04-Feb-2021)

32/33 (96.97%)

$10.41 (6.69%)

867

Show more analysts

Please expand the browser size to see the chart

Which stock is Hartaj Singh most bullish on?

Potential upside of $89.92 has been obtained for VRTX (VERTEX PHARMACEUTICALS)
✖

To continue looking at which analysts cover the stock please register to the basic or advanced membership

What is AnaChart?